Poliomyelitis
Annals.1384.012
Antibody concentration 600 500 400 300 200 100 0 1. Point to the place on the line graph when the antigen A and antigen B are introduced into the body.
National Cancer Institute Development of sero-assays to screen for XMRV antibodies in clinical samples Rachel K. Bagni, Ph.D. December 14, 2010.
Group A3: Immunological endpoints Yacouba Cissoko Agustina Errea Mamadou Korka Diallo.
Medical and Surgical Management of MG Brian A. Crum, MD Department of Neurology Mayo Clinic Rochester, MN MGFA National Meeting, St. Louis May, 2010.
Group A3: Immunological endpoints
MS Research Australia newsletter NEXT 35 - June 2014
